We are recruiting Alzheimer’s disease participants.

We are recruiting participants for a study of the eye and the role of NMDA receptors in Alzheimer’s disease when a treatment decision regarding NAMENDA has been made.

The study does not suggest or interfere with management, and participants can already be on an acetylcholinesterase inhibitor.   We would evaluate participants after treatment decisions regarding NAMENDA are made, but prior to a participant starting to take the medication. A complete eye examination is performed just prior to going on NAMENDA.

In addition to a complete eye examination, Optical Coherence Tomography (OCT), a photography type image of the inside of the eye, and Frequency Doubling Technology (FDT), a very simple side vision/peripheral test, are done. The tests are repeated two additional times.

Examinations can be done at the Boston Medical Center Boston University Eye Associates (BUEA) at Boston University.  They can also be done at the BUEA Brockton clinic located across from the Westgate Mall in Brockton.

Contact: Denise A. Valenti, OD, 617-638-4558 dvalenti@bu.edu